‘Only Marginal Supportive Evidence’ for Bee Venom Therapy in MS Treatment

Examining the Evidence: Complementary Adjunctive Therapies for Multiple Sclerosis
Neurological Research, Volume 30, Number 7, September 2008 , pp. 710-719(10)

Objective: The purpose of this article is to provide a comprehensive overview of the most frequently encountered non-conventional approaches trialed for use in multiple sclerosis (MS). The efficacy and safety of non-conventional approaches ranging from bee venom therapy (BVT) to an array of vitamins and herbal products were discussed and evaluated…

Results: There is presently only marginal supportive evidence for BVT in MS treatment. The inability to identify and quantify the active component of BVT combined with the associated risk of anaphylaxis has deterred its widespread use…